Moreover, CBD administration inhibited macrophage recruitment and suppressed the activation of the NF-κB pathway in the livers of mice with NASH thus confirming the hepatoprotective properties of CBD [32]. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatohepatitis.